ストックスクリーナーアプリを入手
3.97
0.25%
0.01
アフターアワーズ：
4.04
0.07
+1.76%
前日終値:
$3.96
開ける：
$4.595
24時間の取引高:
13.09M
Relative Volume:
1.71
時価総額：
$17.86M
収益：
$6.78M
当期純損益:
$-14.74M
株価収益率:
-0.2462
EPS:
-16.1258
ネットキャッシュフロー:
$-8.51M
1週間 パフォーマンス:
+63.37%
1か月 パフォーマンス:
+264.22%
6か月 パフォーマンス:
+16.42%
1年 パフォーマンス:
-54.05%
1日の値動き範囲:
$3.795
$4.9699
1週間の範囲:
$2.30
$5.38
52週間の値動き範囲:
$0.693
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
名前
Bioaffinity Technologies Inc
セクター
電話
210-698-5334
住所
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
3.97 | 17.81M | 6.78M | -14.74M | -8.51M | -16.13 |
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Bioaffinity Technologies Inc (BIAF) 最新ニュース
bioAffinity Launches Virtual Roundtables on CyPath Lung Adoption - TipRanks
bioAffinity Technologies (BIAF) plans CyPath Lung webinar showcasing real-world clinical use - Stock Titan
BioAffinity Technologies stock soars 120% on CyPath lung sales growth - MSN
BioAffinity’s CyPath Lung Tests Signal Powerful Growth for 2026 - timothysykes.com
BioAffinity Technologies Reports Record Growth Amid Challenges - StocksToTrade
What's Going On With bioAffinity Technologies Stock Wednesday? - Benzinga
bioAffinity Technologies Shows Significant Growth in Diagnostic Development - timothysykes.com
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice - Business Wire
BioAffinity Technologies stock cools off after strong Friday rallyhere's why - MSN
bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction - Mugglehead Investment Magazine
Promising Biotech Stocks To ConsiderMarch 23rd - MarketBeat
bioAffinity Technologies shares soar as investors react to upbeat CyPath Lung growth update and 2026 outlook - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
If You Invested $1,000 in bioAffinity Tech (BIAF) - Stock Titan
What's going on with bioAffinity stock Thursday? - MSN
Big Money Moves: Is bioAffinity Technologies Inc affected by consumer sentimentRate Hike & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Why did BIAF stock surge 20% in pre-market today? - MSN
Top QCM Diagnostics (QCMD) Competitors 2026 - MarketBeat
BIAF Rises Amid Expansions and Innovations - timothysykes.com
Why is bioAffinity Technologies stock surging Tuesday? - MSN
Jobs Data: Can bioAffinity Technologies Inc lead its sector in growthPortfolio Growth Summary & Entry Point Confirmation Alerts - baoquankhu1.vn
What's Going On With bioAffinity Stock Thursday? - Benzinga
BioAffinity Technologies posts 2025 results as CyPath lung testing growth accelerates - MSN
bioAffinity Showcases CyPath Lung Case Study in Diagnostics - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CyPath Lung case study at bioAffinity (NASDAQ: BIAF) shows noninvasive option - Stock Titan
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures - Business Wire
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings - Benzinga
BioAffinity Technologies Eyes Further Expansion Amid Growing Market Demand - StocksToTrade
Why Is bioAffinity Technologies Stock Surging Tuesday? - Benzinga
CyPath Lung Diagnostic Tool Spurs bioAffinity Technologies’ Growth - timothysykes.com
Can bioAffinity Technologies Inc Equity Warrant weather a recessionDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
BioAffinity Technologies, Inc. Releases New Clinical Case Study That Highlights the Benefit of Adding CyPath Lung - marketscreener.com
bioAffinity (NASDAQ: BIAF) proxy adds reverse split and major share authorizations - Stock Titan
bioAffinity Technologies 2024 Annual Report: Business Overview, Clinical Trial Updates, and Key Risks for Diagnostic and Therapeutic Product Development - Minichart
bioAffinity Technologies Stock Cools Off After Strong Friday RallyHere's Why - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
bioAffinity Technologies 10-K: Revenue $6.16M, EPS $(8.66) - TradingView
Form DEF 14A bioAffinity Technologies For: 16 March - Investing.com
Best Small Cap Stocks To Add to Your WatchlistMarch 15th - MarketBeat
Promising Biotech Stocks To Add to Your WatchlistMarch 15th - MarketBeat
Crude Oil Gains Over 1%; VEON Shares Spike Higher - Sahm
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
Promising Small Cap Stocks To ConsiderMarch 14th - MarketBeat
Biotech Stocks To Watch NowMarch 14th - MarketBeat
BioAffinity Technologies Projects Strong Growth Amid Market Fluctuations - timothysykes.com
symbol__ Stock Quote Price and Forecast - CNN
bioAffinity Technologies reports 2025 financial results By Investing.com - Investing.com India
Small Cap Stocks To Follow TodayMarch 13th - MarketBeat
Bioaffinity Technologies Inc (BIAF) 財務データ
収益
当期純利益
現金流量
EPS
0.19%
0.04%
大文字化:
|
ボリューム (24 時間):